A novel copper-hydrogen peroxide formulation for prion decontamination

Journal of Infectious Diseases

Volumn 194, Issue 6, 2006, Pages 865-869

  Solassol, Jérôme ^a,b,e   Pastore, Manuela ^a   Crozet, Carole ^a   Perrier, Véronique ^d   Lehmann, Sylvain ^a,c  

^a INSTITUTE OF HUMAN GENETICS   (France)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c HÔPITAL SAINT ELOI   (France)

^d INSERM   (France)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; HYDROGEN PEROXIDE; ISOPROTEIN; PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASEPSIS; BIOASSAY; BRAIN HOMOGENATE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DRUG FORMULATION; HUMAN; HUMAN TISSUE; INSTRUMENT STERILIZATION; MOUSE; NONHUMAN; PRION; PRIORITY JOURNAL; SCRAPIE AGENT; VIRAL CONTAMINATION; VIRUS INFECTIVITY;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; BIOLOGICAL ASSAY; BRAIN; COPPER; CREUTZFELDT-JAKOB SYNDROME; DECONTAMINATION; HUMANS; HYDROGEN PEROXIDE; MICE; MICE, INBRED C57BL; PRION DISEASES; PRIONS; SCRAPIE; TRACE ELEMENTS;

EID: 33748426775     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/506947     Document Type: Article

References (17)

1. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347:921-5.
2. National Creutzfeldt-Jakob Disease Surveillance Unit (United Kingdom) Web site. Available at: http://www.cjd.ed.ac.uk/figures.htm.
3. Frosh A, Smith LC, Jackson CJ, et al. Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet 2004; 364:1260-2.
4. Glatzel M, Stoeck K, Seeger H, Luhrs T, Aguzzi A. Human prion diseases: molecular and clinical aspects. Arch Neurol 2005; 62:545-52.
5. Axon AT, Beilenhoff U, Bramble MG, et al. Variant Creutzfeldt-Jakob disease (vCJD) and gastrointestinal endoscopy. Endoscopy 2001; 33:1070-80.
6. Lehmann S. Metal ions and prion diseases. Curr Opin Chem Biol 2002; 6:187-92.
7. McMahon HE, Mange A, Nishida N, Creminon C, Casanova D, Lehmann S. Cleavage of the amino-terminus of the prion protein by reactive oxygen species. J Biol Chem 2001; 276:2286-91.
8. Solassol J, Arlotto M, Lehmann S. Detection of prion after decontamination procedures: comparative study of standard Western blot, filter retention and scrapie-cell assay. J Hosp Infect 2004; 57:156-61.
9. McKenzie D, Bartz J, Mirwald J, Olander D, Marsh R, Aiken J. Reversibility of scrapie inactivation is enhanced by copper. J Biol Chem 1998; 273:25545-7.
10. Hijazi N, Shaked Y, Rosenmann H, Ben-Hur T, Gabizon R. Copper binding to PrPC may inhibit prion disease propagation. Brain Res 2003; 993:192-200.
11. Quaglio E, Chiesa R, Harris DA. Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform. J Biol Chem 2001; 276:11432-8.
12. Sagripanti JL, Routson LB, Bonifacino AC, Lytle CD. Mechanism of copper-mediated inactivation of herpes simplex virus. Antimicrob Agents Chemother 1997; 41:812-7.
13. Wong BS, Chen SG, Colucci M, et al. Aberrant metal binding by prion protein in human prion disease. J Neurochem 2001; 78:1400-8.
14. Wadsworth JD, Hill AF, Joiner S, Jackson GS, Clarke AR, Collinge J. Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1999; 1:55-9.
15. Taylor DM. Inactivation of prions by physical and chemical means. J Hosp Infect 1999; 43(Suppl):S69-76.
16. McDonnell G, Burke P. The challenge of prion decontamination. Clin Infect Dis 2003; 36:1152-4.
17. Fichet G, Comoy E, Duval C, et al. Novel methods for disinfection of prion-contaminated medical devices. Lancet 2004; 364:521-6.